Abstract: The present disclosure relates, according to some embodiments, to methods for recovering multiple products from industrial-scale production of a biomass of an aquatic species. Specifically, the present disclosure relates, in some embodiments, to methods for cultivating Lemna for extracting a protein concentrate, a biocrude, and/or a carbohydrate-rich meal. In some embodiments, a process of recovering at least one product from biomass of an aquatic species may comprise: lysing a biomass to generate a lysed biomass; separating the lysed biomass to generate a juice and a first solid phase; filtering the juice to generate a filtered juice and a second solid phase; clarifying at least one juice to generate a clarified juice and a third solid phase, wherein the clarified juice comprises a soluble protein; coagulating the soluble protein from the clarified juice to generate a liquor comprising a wet protein concentrate; and separating the wet protein concentrate from the liquor.

Abstract: The present disclosure relates, according to some embodiments, to methods for recovering multiple products from industrial-scale production of a biomass of an aquatic species. Specifically, the present disclosure relates, in some embodiments, to methods for cultivating Lemna for extracting a protein concentrate, a biocrude, and/or a carbohydrate-rich meal. In some embodiments, a process of recovering at least one product from biomass of an aquatic species may comprise: lysing a biomass to generate a lysed biomass; separating the lysed biomass to generate a juice and a first solid phase; filtering the juice to generate a filtered juice and a second solid phase; clarifying at least one juice to generate a clarified juice and a third solid phase, wherein the clarified juice comprises a soluble protein; coagulating the soluble protein from the clarified juice to generate a liquor comprising a wet protein concentrate; and separating the wet protein concentrate from the liquor.

Abstract: A method for preparation of Timosaponin BII, which uses Chinese traditional medicine Rhizoma Anemarrhenae or fresh rhizoma or fibrous root of Anemarrhena asphodeloides Bge. as raw material, and comprises isolation of Timosaponin BII by one or more processes selected from solvent extraction, resin adsorption, polyamide chromatography, reversed phase column chromatography, Sephadex LH-20 column chromatography, etc, combining with conventional drying method such as reduced pressure drying, freeze drying, spray drying, and so on. Timosaponin BII obtained by the present method is of over 90% purity, and the method is simple, practicable and suitable for industrial production.

Abstract: Smilaxchinoside F compound and its separation method are disclosed. The compound has the structure as following. The use of Smilaxchinoside F in the manufacture of a medicine for treating abnormal angiogenesis and its relating diseases is also disclosed.

Abstract: The present invention provides an extraction method for the leaves of Ilex kudingcha C. J. Tseng, and the total saponins from I. kudingcha leaves extracted by using this method, and use of the total saponins in preparing a drug for reducing cholesterol and blood lipids and anti-atherosclerosis. The extraction method comprises the following steps: subjecting I. kudingcha leaves to refluxing extraction with ethanol aqueous solution to obtain an extracted solution; filtering the extracted solution and removing ethanol, and then separating and purifying the solution using a macroporous resin column.

Abstract: The present invention pertains to methods of extracting cardiac glycosides from cardiac glycoside containing plant material, such as Nerium oleander, through use of aloe. It further provides for compositions resulting from such extractions, pharmaceutical compositions, cosmetic compositions, and methods of treating skin conditions.

Abstract: CAY-1 is a fungicidal saponin from the cayenne pepper (Capsicum frutescens) fruit. The saponins 1081 and 919, closely elute with, and are close structural relatives of, CAY-1. Saponin 1081 is poorly antifungal while 919 has no antifungal properties. Nongerminated and germinating conidia of Aspergilus flavus, A. fumigatus, A. niger, Fusarium oxysporum, F. solani, and F. verticilioides were tested against pure CAY-1 and CAY-1:1081:919 at ratios of 8:1:1, 6:2:2 and 4:3:3 and efficacy was determined after various incubation times. Pure CAY-1 and all saponin mixtures were significantly (p<0.001) lethal to the germinating conidia of A. flavus, A. niger, and F. solani. All saponin mixtures were equal or superior to pure CAY-1 in antifungal properties. Mixtures of the naturally occurring inactive or poorly fungicidal saponins with reduced levels of CAY-1 display superior fungicidal properties when compared to pure CAY-1 at the same dose levels.

Abstract: Smilaxchinoside F compound and its separation method are disclosed. The compound has the structure as following. The use of Smilaxchinoside F in the manufacture of a medicine for treating abnormal angiogenesis and its relating diseases is also disclosed.

Abstract: A novel, commercially viable process for the extraction of high purity (>70%), bioactive furostanolic saponins including protodioscin (>30%), from the seeds of fenugreek (Trigonella foenumgraecum) comprising essentially the steps of powdering of the natural material followed by a first extraction, an ion-exchange chromatographic purification and a second extraction using a novel composite solvent and drying of the product under defined conditions, the entire process being carried out at essentially neutral pH and low temperatures of less than 80° C.

Abstract: The present invention provides a gene that codes for a protein, wherein the protein is an anthocyanin 5-O-glucosyltransferase, which is an enzyme that transfers a glycoside to the 5 position of a flavonoid. The disclosed anthocyanin 5-O-glucosyltransferases were isolated from Perilla fruescens, Verbena hybrida, Torenia hybrida, and Petunia hybrida. Also disclosed are genes that code for a protein having a modified amino acid sequence relative to the above amino acid sequence and having activity that transfers a glycoside to the 5 position of a flavonoid, and a process for producing the above protein using said gene. This gene can be used to artificially alter the color of plants.

Abstract: A process for the preparation of desglucodesrhamnoruscin which comprises the enzymatic hydrolysis of Ruscus Aculeatus steroid glycosides (ruscosaponins) by means of crude hydrolases from aspergillus niger.

Abstract: This invention discloses a compound (I) of the following formula. This invention also includes a method for extracting the compound (I), and a pharmaceutical composition containing the compound (I). The extracting method includes the following steps: taking the corpus radicis and/or radix fibrosa of a ginseng spp. plant—ginseng or pseudo-ginseng, extracting with industrial alcohol and n-butanol to extract the total saponins, and then purifying by silicon gel column chromatography and reversed phase column chromatography to obtain the compound (I). The compound (I) and pharmaceutical composition can be used to cure acute ischemic cerebral-vascular diseases.

Abstract: The present invention relates to a process for the isolation of a novel oligospirostanoside structurally constructed as 3-0-[&agr;-L-rhamnopyranosyl-(1→2)-&agr;-L-rhamnopyranosyl-(1→4)-0-&bgr;-D-glucopyranosyl]-25(S)-spirostan-3&bgr;-ol isolated from Asparagus racemosus and biologically evaluated as a potent immunomodulatory agent.

Abstract: This invention discloses a compound (I) of the following formula. This invention also includes a method for extracting the compound (I), and a pharmaceutical composition containing the compound (I). The extracting method includes the following steps: taking the corpus radicis and/or radix fibrosa of a ginseng spp. plant—ginseng or pseudo-ginseng, extracting with industrial alcohol and n-butanol to extract the total saponins, and then purifying by silicon gel column chromatography and reversed phase column chromatography to obtain the compound (I). The compound (I) and pharmaceutical composition can be used to cure acute ischemic cerebral-vascular diseases.

Abstract: A method of producing betulinic acid from the bark of plane trees by fractional extraction with a solvent of medium polarity and subsequent recrystallization out of methanol.